RecruitingNCT06727331
Tirzepatide for Recovery and Alcohol Use Management
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesAddictionBehavioralOver 18 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
RecruitingNCT06238700
Study on Allopregnanolone and Depression in Women Across the Menopause Transition
This study is looking at identify how enhanced allopregnanolone activity (via pregnenolone) affects behavior and neurobiology that may underlie perimenopausal depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
In United StatesDepressionBehavioralFrom 40 Years to 60 Years
RecruitingNCT06846320
Adverse Events and Change for anxiety
This study is recruiting in the United States. It is testing adverse Events and Change for anxiety.
In United StatesAnxietyBehavioralFrom 18 Years to 65 Years
RecruitingNCT07220460
Adverse Events of Oral ABBV-932 for depression
This study is recruiting in the United States. It is testing Adverse Events of Oral ABBV-932 for depression.
In United StatesBipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
RecruitingNCT06786624
NBI-1065845 for depression
This study is recruiting in the United States. It is testing NBI-1065845 for depression.
In United StatesDepressionDrugOver 18 Years
RecruitingNCT07467993
Safety, Tolerability, and Treatment Response of GXV813 for schizophrenia
This study is recruiting in the United States and in Bulgaria. It is testing Safety, Tolerability, and Treatment Response of GXV813 for schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 65 Years
RecruitingNCT06538558
Use of Tezampanel for Addiction
This study is recruiting in the United States. It is testing use of Tezampanel for Addiction.
In United StatesAddictionDrugFrom 18 Years to 65 Years
RecruitingNCT07565428
Roluperidone for schizophrenia
This study is recruiting in the United States. It is testing roluperidone for schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 55 Years
RecruitingNCT07363577
LB-102 for schizophrenia
This study is recruiting in the United States. It is testing LB-102 for schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 65 Years
RecruitingNCT07221578
VQW-765 for anxiety
This study is recruiting in the United States. It is testing VQW-765 for anxiety.
Remote / onlineAnxietyDrugFrom 18 Years to 65 Years
RecruitingNCT05303064
Weight Gain for schizophrenia
This study is recruiting in the United States, in Argentina, in Brazil, .... It is testing weight Gain for schizophrenia.
In United StatesBipolarity, SchizophreniaDrugFrom 10 Years to 17 Years
RecruitingNCT07639359
Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesDepressionDrugFrom 18 Years to 99 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.